Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Clinical and Translational Science|October 27, 2021
Population pharmacokinetic/pharmacodynamic assessment of imipenem/cilastatin/relebactam in patients with hospital-acquired/ventilator-associated bacterial pneumoniaMunjal Patel, Francesco Bellanti, Naveen M Daryani, et al.
Clinical Pharmacology and Therapeutics|April 14, 2026
The Future of Clinical Translational PharmacologyMatthew L Rizk, Anuradha Ramamoorthy, Stephani L Stancil, et al.
Clinical Pharmacology in Drug Development|March 27, 2020
Thorough QTc Study of a Single Supratherapeutic Dose of Relebactam in Healthy ParticipantsKeith Boundy, Yang Liu, Pratik Bhagunde, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 16, 2018
Perspective on the State of Pharmacometrics and Systems Pharmacology IntegrationMirjam N Trame, Matthew Riggs, Konstantinos Biliouris, et al.
Therapeutic Innovation & Regulatory Science|September 21, 2018
Novel Gastroretentive Controlled Release Formulations for Once-Daily Administration: Assessment of Clinical Feasibility and Formulation Concept for RaltegravirRajesh Krishna, Matthew L Rizk, Patrick J Larson, et al.
Pediatric Pulmonology|May 19, 2020
Plasma pharmacokinetics of ceftolozane/tazobactam in pediatric patients with cystic fibrosisAntonio C Arrieta, Jocelyn Y Ang, Zufei Zhang, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2012
Pharmacokinetics and pharmacodynamics of once-daily versus twice-daily raltegravir in treatment-naive HIV-infected patientsMatthew L Rizk, Yaming Hang, Wen-Lin Luo, et al.
Alimentary Pharmacology & Therapeutics|February 21, 2025
Clinical Trial: A Phase 2b Study to Evaluate the Efficacy and Safety of MK-3655 in Individuals With Pre-Cirrhotic MASHAnnaswamy Raji, Ira Gantz, Michael Crutchlow, et al.
Clinical and Translational Science|April 9, 2024
Molnupiravir: Mechanism of action, clinical, and translational scienceBrian M Maas, Julie Strizki, Randy R Miller, et al.
International Journal of Antimicrobial Agents|February 10, 2021
Pharmacokinetics and Pharmacodynamics of Ceftolozane/Tazobactam in Critically Ill Patients With Augmented Renal ClearanceDavid P Nicolau, Jan De Waele, Joseph L Kuti, et al.
Pageof 6